Evidence map›Paper›PMID 24927554›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Cofactor-dependent conformational heterogeneity of GAD65 and its role in autoimmunity and neurotransmitter homeostasis.

Itamar Kass, David E Hoke, Mauricio G S Costa, Cyril F Reboul, Benjamin T Porebski, Nathan P Cowieson, Hervé Leh, Eugenia Pennacchietti, Julia McCoey, Oded Kleifeld and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. The role of GABA in type 1 diabetes.Frontiers in endocrinology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. The role of GABA in islet function.Frontiers in endocrinology · 2022
    Review
  12. Article
  13. Exposing the distinctive modular behavior of β-strands and α-helices in folded proteins.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. Article
  15. Article
  16. [Research advances in pathogenesis of attention deficit hyperactivity disorder].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2018
    Article
  17. Article
  18. Islet Autoantibodies.Current diabetes reports · 2016
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 4 countries.

Itamar KassDepartment of Biochemistry and Molecular Biology,Victorian Life Sciences Computation Initiative Life Sciences Computation Centre, and.
David E HokeDepartment of Biochemistry and Molecular Biology.
Mauricio G S CostaPrograma de Computação Científica, Fundação Oswaldo Cruz, 21949900 Rio de Janeiro, Brazil;
Cyril F ReboulDepartment of Biochemistry and Molecular Biology,Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Monash University, Clayton, VIC 3800, Australia;
Benjamin T PorebskiDepartment of Biochemistry and Molecular Biology.
Nathan P CowiesonAustralian Synchrotron, VIC 3168, Australia;
Hervé LehLaboratoire de Biologie et de Pharmacologie Appliquée, Ecole Normale Supérieure de Cachan, Centre National de la Recherche Scientifique, 61, F-94235 Cachan, France;
Eugenia PennacchiettiIstituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze e Biotecnologie Medico-Chirurgiche, Sapienza Università di Roma, 04100 Latina, Italy;
Julia McCoeyDepartment of Biochemistry and Molecular Biology.
Oded KleifeldDepartment of Biochemistry and Molecular Biology.
Carla Borri VoltattorniDipartimento di Scienze della Vita e della Riproduzione, Sezione di Chimica Biologica, Facoltà di Medicina e Chirurgia, Università degli Studi di Verona, 37134 Verona, Italy;
David LangleyGarvan Institute of Medical Research, Darlinghurst/Sydney, NSW 2010, Australia; and.
Brendan RoomeGarvan Institute of Medical Research, Darlinghurst/Sydney, NSW 2010, Australia; and.
Ian R MackayDepartment of Biochemistry and Molecular Biology.
Daniel ChristGarvan Institute of Medical Research, Darlinghurst/Sydney, NSW 2010, Australia; and.
David PerahiaLaboratoire de Biologie et de Pharmacologie Appliquée, Ecole Normale Supérieure de Cachan, Centre National de la Recherche Scientifique, 61, F-94235 Cachan, France;
Malcolm BuckleLaboratoire de Biologie et de Pharmacologie Appliquée, Ecole Normale Supérieure de Cachan, Centre National de la Recherche Scientifique, 61, F-94235 Cachan, France;
Alessandro PaiardiniDipartimento di Scienze Biochimiche "A. Rossi Fanelli," Sapienza Università di Roma, 00185 Rome, Italy.
Daniela De BiaseIstituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze e Biotecnologie Medico-Chirurgiche, Sapienza Università di Roma, 04100 Latina, Italy;
Ashley M BuckleDepartment of Biochemistry and Molecular Biology, ashley.buckle@monash.edu.
Garvan Institute of Medical Research · AULaboratoire de Biologie et Pharmacologie Appliquée · FRIstituto Pasteur · ITAustralian Research Council · AUAustralian Synchrotron · AUFundação Oswaldo Cruz · BRMelbourne Bioinformatics · AUSapienza University of Rome · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The human neuroendocrine enzyme glutamate decarboxylase (GAD) catalyses the synthesis of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) using pyridoxal 5'-phosphate as a cofactor. GAD exists as two isoforms named according to their respective molecular weights: GAD65 and GAD67. Although cytosolic GAD67 is typically saturated with the cofactor (holoGAD67) and constitutively active to produce basal levels of GABA, the membrane-associated GAD65 exists mainly as the inactive apo form. GAD65, but not GAD67, is a prevalent autoantigen, with autoantibodies to GAD65 being detected at high frequency in patients with autoimmune (type 1) diabetes and certain other autoimmune disorders. The significance of GAD65 autoinactivation into the apo form for regulation of neurotransmitter levels and autoantibody reactivity is not understood. We have used computational and experimental approaches to decipher the nature of the holo → apo conversion in GAD65 and thus, its mechanism of autoinactivation. Molecular dynamics simulations of GAD65 reveal coupling between the C-terminal domain, catalytic loop, and pyridoxal 5'-phosphate-binding domain that drives structural rearrangement, dimer opening, and autoinactivation, consistent with limited proteolysis fragmentation patterns. Together with small-angle X-ray scattering and fluorescence spectroscopy data, our findings are consistent with apoGAD65 existing as an ensemble of conformations. Antibody-binding kinetics suggest a mechanism of mutually induced conformational changes, implicating the flexibility of apoGAD65 in its autoantigenicity. Although conformational diversity may provide a mechanism for cofactor-controlled regulation of neurotransmitter biosynthesis, it may also come at a cost of insufficient development of immune self-tolerance that favors the production of GAD65 autoantibodies.

Indexed as

Autoimmunitygamma-Aminobutyric AcidGlutamate DecarboxylaseMolecular Dynamics SimulationNeurotransmitter AgentsAutoantibodiesDiabetes Mellitus, Type 1HomeostasisHumansProtein MultimerizationStructure-Activity RelationshipAutoantibodiesgamma-Aminobutyric AcidGlutamate Decarboxylaseglutamate decarboxylase 2Neurotransmitter Agentsautoepitopesconformational dynamicsGABA biosynthesisimmunogenicitynormal mode analysis

Identifiers

PMID24927554
PMCPMC4078817
OpenAlexW1993062686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.